Evaluation of Intradetrusor AbobotulinumtoxinA and IncobotulinumtoxinA in Women With Overactive Bladder

Conditions: Overactive Bladder Interventions: Drug: AbobotulinumtoxinA 300 UNT; Drug: IncobotulinumtoxinA 100 UNT; Drug: Lidocain; Other: placebo Sponsors: Niko Kavcic Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials